PEPTIDE

Klow

KLOW is a synergistic four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV. Formulated for regenerative research applications, it simultaneously targets inflammation modulation, multi-tissue repair, angiogenesis, cellular regeneration, and skin rejuvenation.

KLOW is an advanced, synergistic lyophilized four-peptide research formulation (80mg total per vial: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV) optimized for multi-pathway regenerative and anti-inflammatory research. Each component delivers complementary biological activity:

KPV: Provides targeted anti-inflammatory and immune-modulating effects to downregulate excessive inflammatory signaling
BPC-157: is studied in relation to multi-tissue repair (tendons, ligaments, muscle, gastrointestinal mucosa) and broad cytoprotection across organ systems
TB-500: Promotes angiogenesis, directed cell migration, and coordinated tissue remodeling to support wound and injury recovery
GHK-Cu: Stimulates collagen and elastin synthesis, supports extracellular matrix remodeling, and enhances skin rejuvenation

Designed for preclinical and in vitro research, KLOW enables investigation of combined regenerative pathways in models of post-injury recovery, post-surgical healing, gut mucosal repair, skin anti-aging, and chronic inflammation. All components are manufactured to ≥99% purity, sterile-filtered, and lyophilized for long-term stability.

For laboratory research use only; not intended for human or veterinary administration.

Research use only: This material is supplied for laboratory research and documentation workflows only. It is not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.

Hytan procurement and documentation support

For Klow, Hytan Peptides can support research-use sourcing review with available batch COA, vial labeling, product identity notes, storage documentation and wholesale quantity discussion. Product-specific CAS, sequence, molecular weight or method details should be confirmed against the current batch document before procurement decisions.

COA review: request batch-specific purity and identity references where available.
Wholesale planning: confirm vial strength, quantity, lead time, packing and destination requirements.
Compliance: research-use wording should remain clear in quote, invoice and receiving records.

Manufacturing Capability

Controlled production for consistent research peptide supply

Hytan Peptides supports wholesale research peptide orders with organized production workflow, clean handling, standardized filling, labeling and batch-level documentation. From material preparation to final review, each step is managed to support consistent appearance, traceable COA records and dependable supply coordination.

This production overview helps laboratories, distributors and qualified research buyers understand how Hytan Peptides approaches quality-focused peptide manufacturing, packaging and order readiness.